New obesity drug HCR-188 enters first human safety trial
Disease control
Terminated
This early-stage study tests a new drug called HCR-188 in 48 overweight or obese adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo as injections. The goal is to check for side effects and gather initial information, not t…
Phase: EARLY_PHASE1 • Sponsor: Helicore Biopharma, Inc. • Aim: Disease control
Last updated May 17, 2026 11:35 UTC